Fabrizio Schifano

St George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 222 publications

Crawling into the Unknown: Unveiling Novel Psychoactive Substances (NPSs) in the Post Pandemic Era Utilizing the NPSfinder®.

Crawling into the Unknown: Unveiling Novel Psychoactive Substances (NPSs) in the Post Pandemic Era Utilizing the NPSfinder®.

Journal: International journal of toxicology

Published: July 31, 2026

Possible Signals of Ocular Disorders Associated with Gabapentinoids: A Three-Arm Study.

Possible Signals of Ocular Disorders Associated with Gabapentinoids: A Three-Arm Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 15, 2026

GLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation.

GLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation.

Journal: Current psychiatry reports

Published: May 21, 2026

Psychopharmacology of Methamphetamine in Relation to the United Kingdom Sentencing Guidance: Comparative Analysis with Amphetamine, Cocaine and Heroin.

Psychopharmacology of Methamphetamine in Relation to the United Kingdom Sentencing Guidance: Comparative Analysis with Amphetamine, Cocaine and Heroin.

Journal: Brain sciences

Published: April 10, 2026

Health-Related Quality of Life in Previous Versus Current Opiate Users Receiving HCV Therapy: Registry-Based Evidence.

Health-Related Quality of Life in Previous Versus Current Opiate Users Receiving HCV Therapy: Registry-Based Evidence.

Journal: Brain sciences

Published: February 27, 2026

Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment.

Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment.

Journal: Brain sciences

Published: February 06, 2026

Reply to Comment on: "Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS Database".

Reply to Comment on: "Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS Database".

Journal: American journal of ophthalmology

Published: February 01, 2026

Treatment and management approaches for ketamine misuse: A systematic review of medical interventions.

Treatment and management approaches for ketamine misuse: A systematic review of medical interventions.

Journal: Journal of substance use and addiction treatment

Published: December 03, 2025

Novel Synthetic Opioids (NSOs) and Their Evolving Crisis: Utilising NPSfinder® as a Real-Time Predictive Tool.

Novel Synthetic Opioids (NSOs) and Their Evolving Crisis: Utilising NPSfinder® as a Real-Time Predictive Tool.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 15, 2025

Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS (FDA Adverse Event Reporting System) Database.

Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS (FDA Adverse Event Reporting System) Database.

Journal: American journal of ophthalmology

Published: October 23, 2025

Managing Dual Diagnosis Patients and the Importance of Assessing Capacity: Data from London Inpatient Services.

Managing Dual Diagnosis Patients and the Importance of Assessing Capacity: Data from London Inpatient Services.

Journal: Brain sciences

Published: October 07, 2025

Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database.

Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database.

Journal: Brain sciences

Published: October 03, 2025

Showing 1-12 of 222

Last Updated: 09/26/2026